Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Complement C3 Depletion in Patients With Severe Abdominal Sepsis: Risk Prediction and the Association With Down-regulated Adaptive Immunity

NCT01568853 is registered in ClinicalTrials.gov with Jinling Hospital, China as lead sponsor.

NCT NCT01568853
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01568853 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Complement C3 Depletion in Patients With Severe Abdominal Sepsis: Risk Prediction and the Association With Down-regulated Adaptive Immunity
Lead sponsor
Jinling Hospital, China
Phase
Not applicable
Overall status
Completed
Start date
November 30, 2011
Completion date
March 31, 2012
Enrollment
75 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

abdominal abscess, appendicitis, digestive system fistula, pancreatitis, severe sepsis